tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

IVD Medical Proposes New General Mandate to Enhance Capital Flexibility

Story Highlights
IVD Medical Proposes New General Mandate to Enhance Capital Flexibility

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An announcement from IVD Medical Holding Limited ( (HK:1931) ) is now available.

IVD Medical Holding Limited has announced a proposal to refresh its General Mandate, allowing the Directors to issue new shares up to 20% of the company’s issued share capital. This move is necessary as the existing mandate has been fully utilized following a previous acquisition. The proposal requires approval from independent shareholders at an Extraordinary General Meeting (EGM), and an Independent Board Committee has been established to advise on the matter. The decision aims to provide the company with greater flexibility in managing its capital and supporting future growth initiatives.

The most recent analyst rating on (HK:1931) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on IVD Medical Holding Limited stock, see the HK:1931 Stock Forecast page.

More about IVD Medical Holding Limited

IVD Medical Holding Limited is a company incorporated in the Cayman Islands, operating in the medical industry. It focuses on providing medical solutions and services, with a particular emphasis on the distribution and development of in vitro diagnostic products.

Average Trading Volume: 2,234,395

Technical Sentiment Signal: Buy

Current Market Cap: HK$18.21B

Learn more about 1931 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1